Kun Liu
58Patents
9h-index
160Co-inventors
81Inventor score
Filing activity: Feb 13, 1992 → Dec 12, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8871759B2 | Inhibitors of hepatitis C virus replication | Chemistry; Metallurgy | 49 | Active |
| US6569879B2 | Aryloxyacetic acids for diabetes and lipid disorders | Human Necessities | 40 | Expired |
| US6319695A | Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose | Chemistry; Metallurgy | 36 | Expired |
| US9120781B2 | Selective glycosidase inhibitors and uses thereof | Chemistry; Metallurgy | 24 | Active |
| US5276120A | Process for forming omega-deuxy-azasugars | Chemistry; Metallurgy | 22 | Expired |
| US5596005A | Omega-deoxy-azasugars | Chemistry; Metallurgy | 17 | Expired |
| US9663502B2 | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease | Chemistry; Metallurgy | 12 | Active |
| US7335500B2 | Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose | Chemistry; Metallurgy | 10 | Expired |
| US9783511B2 | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 9 | Active |
| US9809561B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 8 | Active |
| US8933040B2 | Selective glycosidase inhibitors and uses thereof | Physics | 8 | Active |
| US8933113B2 | Mineralocorticoid receptor antagonists | Chemistry; Metallurgy | 8 | Active |
| US8927507B2 | Selective glycosidase inhibitors and uses thereof | Physics | 8 | Active |
| US10221146B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 6 | Active |
| US9090661B2 | Inhibitors of hepatitis C virus replication | Chemistry; Metallurgy | 6 | Active |
| US7186746B2 | Indoles having anti-diabetic activity | Chemistry; Metallurgy | 6 | Expired |
| US9938299B2 | Glycosidase inhibitors and uses thereof | Performing Operations; Transporting | 5 | Active |
| US5229523A | 2-methyl-5-hydroxymethyl- and 2,5-dimethyl-3,4-dihydroxypyrrolidines | Chemistry; Metallurgy | 4 | Expired |
| US10221142B2 | Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US7345085B2 | Indoles having anti-diabetic activity | Chemistry; Metallurgy | 3 | Active |
| US6077849A | Antidiabetic agents | Chemistry; Metallurgy | 2 | Expired |
| US10287272B2 | Substituted indazole compounds as RORgammaT inhibitors and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US7625933B2 | Indoles having anti-diabetic activity | Chemistry; Metallurgy | 2 | Active |
| US11312719B2 | 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | Emerging Cross-Sectional Technologies | 1 | Active |
| US8901087B2 | Selective glycosidase inhibitors and uses thereof | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.